Topical skin formulations
AssigneeMary Kay Inc.
InventorsTiffany Carle, Bob Foley, Julia Collier, Wanli Zhao, Geetha Kalahasti
Life of this patent
Estimating the term…
Abstract
A method of treating skin is disclosed. The method can include topically applying to a peron's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.
Claims10
A method of treating a human with erythemic skin, the method comprising topically applying to said human a composition comprising:
- 0. 0001% to 5% w/w of a hydrolyzed algae extract;
- 0.0001% to 5% w/w of a saccharide isomerate;
- at least one of octinoxate, homosalate, oxybenzone, octisalate, avobenzone, octocrylene, titanium dioxide, and zinc oxide;
- and
- a dermatologically acceptable vehicle,
- wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNF-a production is inhibited in the skin, wherein the hydrolyzed algae extract comprises exopolysaccharides from Halymenia durvillei, and wherein the saccharide isomerate comprises an exopolysaccharide synthesized by Vibrio alginolyticus.
Dependencies are inferred from the claim text.